Edition:
United Kingdom

Amarin Corporation PLC (AMRN.OQ)

AMRN.OQ on NASDAQ Stock Exchange Global Market

18.08USD
14 Jun 2019
Change (% chg)

$-0.58 (-3.11%)
Prev Close
$18.66
Open
$18.83
Day's High
$18.85
Day's Low
$17.90
Volume
1,300,470
Avg. Vol
1,542,755
52-wk High
$23.33
52-wk Low
$2.36

About

Amarin Corporation plc is a biopharmaceutical company with operations in lipid science focused on the commercialization and development of therapeutics for cardiovascular health. The Company operates through the development and commercialization of Vascepa segment. The Company's lead product, Vascepa (icosapent ethyl) capsule,... (more)

Overall

Beta: 0.65
Market Cap(Mil.): $950.48
Shares Outstanding(Mil.): 270.79
Dividend: --
Yield (%): --

Financials

  AMRN.OQ Industry Sector
P/E (TTM): -- 69.30 32.55
EPS (TTM): -0.31 -- --
ROI: -101.25 8.90 13.82
ROE: -- 10.04 15.24

Amarin's Vascepa cuts occurrence of serious heart problems 30 percent: study

A high dose of Amarin Corp's Omega-3 drug Vascepa significantly reduced the occurrence of first and subsequent heart attacks, strokes and other serious heart problems in high-risk patients already taking cholesterol medication by even more than initially reported, according to data presented on Monday.

18 Mar 2019

Amarin's Vascepa cuts occurrence of serious heart problems 30 pct -study

March 18 A high dose of Amarin Corp's Omega-3 drug Vascepa significantly reduced the occurrence of first and subsequent heart attacks, strokes and other serious heart problems in high-risk patients already taking cholesterol medication by even more than initially reported, according to data presented on Monday.

18 Mar 2019

Earnings vs. Estimates